Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in treatments for hematologic diseases, has announced its participation in the H.C. Wainwright 3rd Annual BioConnect Investor Conference. The company's management will engage in a fireside chat on Tuesday, May 20th at 9:00 am ET. Investors can access the live webcast through Disc Medicine's investor relations website at ir.discmedicine.com, with an archived replay available after the event.

WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in a fireside chat at the H.C. Wainwright 3^rd Annual BioConnect Investor Conference on Tuesday, May 20^th at 9:00 am ET.

A live webcast of the fireside chat will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com

FAQ

When is Disc Medicine (IRON) presenting at the H.C. Wainwright BioConnect Conference?

Disc Medicine will participate in a fireside chat at the H.C. Wainwright BioConnect Conference on Tuesday, May 20th at 9:00 am ET.

How can investors watch Disc Medicine's (IRON) presentation at the H.C. Wainwright Conference?

Investors can watch the live webcast through Disc Medicine's investor relations website at ir.discmedicine.com. An archived replay will be available after the event.

What is Disc Medicine's (IRON) main business focus?

Disc Medicine is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel treatments for patients with serious hematologic diseases.

What type of event will Disc Medicine (IRON) participate in at the H.C. Wainwright Conference?

Disc Medicine's management will participate in a fireside chat format presentation at the conference.